Pharma firms pay back Canada Can$7.9 million; bulk from Novo Nordisk
This article was originally published in Scrip
Executive Summary
Pharmaceutical firms continue to make payments to the Canadian government to offset cumulative excess revenues gained, withpay backs hitting some Can$7.9 million ($7.7 million) so far this year, with Novo Nordisk making the bulk of this year's payment.